Things Look Grim For Nu Skin Enterprises, Inc. (NYSE:NUS) After Today's Downgrade
Things Look Grim For Nu Skin Enterprises, Inc. (NYSE:NUS) After Today's Downgrade
The latest analyst coverage could presage a bad day for Nu Skin Enterprises, Inc. (NYSE:NUS), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little shell-shocked. Both revenue and earnings per share (EPS) forecasts went under the knife, suggesting analysts have soured majorly on the business.
分析师的最新报道可能预示着Nu Skin Enterprises, Inc.(纽约证券交易所代码:NUS)将迎来糟糕的一天,分析师全面下调了法定估计,这可能会让股东感到震惊。收入和每股收益(EPS)的预测都出现了偏差,这表明分析师对该业务的看法主要恶化。
Following the latest downgrade, the three analysts covering Nu Skin Enterprises provided consensus estimates of US$1.8b revenue in 2024, which would reflect a measurable 7.9% decline on its sales over the past 12 months. Statutory earnings per share are presumed to bounce 473% to US$0.99. Prior to this update, the analysts had been forecasting revenues of US$2.0b and earnings per share (EPS) of US$2.15 in 2024. Indeed, we can see that the analysts are a lot more bearish about Nu Skin Enterprises' prospects, administering a measurable cut to revenue estimates and slashing their EPS estimates to boot.
在最近的降级之后,涵盖Nu Skin Enterprises的三位分析师提供了共识估计,2024年收入为18亿美元,这将反映出其在过去12个月中销售额明显下降了7.9%。据推测,每股法定收益将反弹473%,至0.99美元。在本次更新之前,分析师一直预测2024年的收入为20亿美元,每股收益(EPS)为2.15美元。事实上,我们可以看到,分析师对Nu Skin Enterprises的前景更加悲观,他们大幅削减了收入预期,并下调了每股收益预期。
![earnings-and-revenue-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240220/0-3d6cab2a4e74e80d1ac8776148b51b41-0-da6bcea6c89a75964e5920f9e3778b14.png/big)
The consensus price target fell 26% to US$15.50, with the weaker earnings outlook clearly leading analyst valuation estimates.
共识目标股价下跌26%,至15.50美元,盈利前景疲软显然领先于分析师的估值预期。
Of course, another way to look at these forecasts is to place them into context against the industry itself. Over the past five years, revenues have declined around 4.2% annually. Worse, forecasts are essentially predicting the decline to accelerate, with the estimate for an annualised 7.9% decline in revenue until the end of 2024. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 7.1% per year. So while a broad number of companies are forecast to grow, unfortunately Nu Skin Enterprises is expected to see its sales affected worse than other companies in the industry.
当然,看待这些预测的另一种方法是将它们与行业本身联系起来。在过去五年中,收入每年下降约4.2%。更糟糕的是,预测本质上是预测下降将加速,预计到2024年底,收入年化下降7.9%。相比之下,我们的数据表明,预计类似行业的其他公司(有分析师报道)的收入每年将增长7.1%。因此,尽管预计将有许多公司增长,但不幸的是,预计Nu Skin Enterprises的销售受到的影响将比业内其他公司更严重。
The Bottom Line
底线
The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Nu Skin Enterprises. Unfortunately analysts also downgraded their revenue estimates, and industry data suggests that Nu Skin Enterprises' revenues are expected to grow slower than the wider market. After such a stark change in sentiment from analysts, we'd understand if readers now felt a bit wary of Nu Skin Enterprises.
新估计中最大的问题是,分析师下调了每股收益预期,这表明Nu Skin Enterprises面临业务不利因素。不幸的是,分析师也下调了收入预期,行业数据表明,预计Nu Skin Enterprises的收入增长将低于整个市场。在分析师的观点发生了如此明显的变化之后,我们可以理解读者现在是否对Nu Skin Enterprises感到有些警惕。
Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. At Simply Wall St, we have a full range of analyst estimates for Nu Skin Enterprises going out to 2025, and you can see them free on our platform here.
即便如此,业务的长期发展轨迹对于股东的价值创造更为重要。在Simply Wall St,我们有分析师对Nu Skin Enterprises到2025年的全方位估计,你可以在我们的平台上免费查看。
Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.
当然,看到公司管理层将大量资金投资于股票与了解分析师是否在下调预期一样有用。因此,您可能还希望搜索这份内部人士正在购买的免费股票清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。